State Street’s Werewolf Therapeutics HOWL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.2K Hold
119,168
﹤0.01% 4027
2025
Q4
$75.5K Hold
119,168
﹤0.01% 4094
2025
Q3
$235K Hold
119,168
﹤0.01% 3866
2025
Q2
$130K Sell
119,168
-325,104
-73% -$335K ﹤0.01% 3925
2025
Q1
$432K Buy
444,272
+17,500
+4% +$22.9K ﹤0.01% 3626
2024
Q4
$632K Sell
426,772
-49,667
-10% -$101K ﹤0.01% 3574
2024
Q3
$1.01M Buy
476,439
+52,528
+12% +$119K ﹤0.01% 3484
2024
Q2
$1.03M Buy
423,911
+352,743
+496% +$1.69M ﹤0.01% 3470
2024
Q1
$461K Sell
71,168
-12,300
-15% -$71.7K ﹤0.01% 3670
2023
Q4
$322K Buy
83,468
+32,700
+64% +$83.5K ﹤0.01% 3759
2023
Q3
$109K Hold
50,768
﹤0.01% 4093
2023
Q2
$155K Hold
50,768
﹤0.01% 4084
2023
Q1
$132K Buy
50,768
+17,800
+54% +$53.1K ﹤0.01% 4229
2022
Q4
$67.6K Buy
32,968
+8,400
+34% +$22K ﹤0.01% 4480
2022
Q3
$111K Hold
24,568
﹤0.01% 4432
2022
Q2
$100K Sell
24,568
-310,519
-93% -$1.42M ﹤0.01% 4536
2022
Q1
$1.47M Buy
335,087
+75,461
+29% +$529K ﹤0.01% 3671
2021
Q4
$3.09M Buy
259,626
+143,562
+124% +$2.17M ﹤0.01% 3475
2021
Q3
$1.99M Buy
116,064
+37,827
+48% +$645K ﹤0.01% 3614
2021
Q2
$1.36M Buy
+78,237
New +$1.07M ﹤0.01% 3614

Other funds holding HOWL

State Street's HOWL Position: Q1 2026 in Review

State Street held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 119,168 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4027.

State Street first reported a position in HOWL in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.09M in Q4 2021. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • State Street held 119,168 shares of Werewolf Therapeutics worth $99.2K as of Q1 2026.
  • State Street left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4027 holding.
  • State Street first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • State Street's Werewolf Therapeutics position peaked at $3.09M in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.